A Study of TIL in Advanced Solid Tumors (DFGD)

Clinical trial NCT06488950 · RECRUITING

Trial details

NCT number: NCT06488950
Sponsor: Shanghai Juncell Therapeutics
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Tumor Infiltrating Lymphocytes Treatment Side Effects Effects of Immunotherapy

Start date: 2023-04-01
Primary completion: 2026-06-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.